Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J Taber

Showing results (101-110 of 209) with videos related to

Pageof 21
Sort By:
Transplant International : Official Journal of the European Society for Organ Transplantation|January 14, 2020
Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort studyErin R Weeda, Zemin Su, David J Taber, et al.
Journal of the American College of Surgeons|February 9, 2020
Virtual Crossmatching in Kidney Transplantation: The Wait Is OverVinayak S Rohan, Nicole Pilch, Omar Moussa, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 24, 2012
Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipientsDavid J Taber, Nicole A Pilch, John W McGillicuddy, et al.
The Annals of Pharmacotherapy|September 9, 2021
A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled TrialHaley M Gonzales, James N Fleming, Mulugeta Gebregziabher, et al.
Transplantation Proceedings|December 23, 2008
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantationD J Taber, N A Weimert, F Henderson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2016
A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant RecipientsDavid J Taber, Kelly J Hunt, Mulugeta Gebregziabher, et al.
Annals of Surgery|June 28, 2017
Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant RecipientsDavid J Taber, John W McGillicuddy, Charles F Bratton, et al.
Journal of the American College of Surgeons|March 15, 2022
Early Assessment of National Kidney Allocation Policy ChangeVinayak S Rohan, Nicole Pilch, John McGillicuddy, et al.
Journal of the American College of Surgeons|February 5, 2017
Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney TransplantationDavid J Taber, Derek DuBay, John W McGillicuddy, et al.
Kidney International|August 25, 2016
Twenty years of evolving trends in racial disparities for adult kidney transplant recipientsDavid J Taber, Mulugeta Gebregziabher, Kelly J Hunt, et al.
Pageof 21

Showing results (101-110 of 209) with videos related to

Sort By:
Pageof 21
Transplant International : Official Journal of the European Society for Organ Transplantation|January 14, 2020
Costs and factors associated with heart failure following kidney transplantation - a single-center retrospective cohort studyErin R Weeda, Zemin Su, David J Taber, et al.
Journal of the American College of Surgeons|February 9, 2020
Virtual Crossmatching in Kidney Transplantation: The Wait Is OverVinayak S Rohan, Nicole Pilch, Omar Moussa, et al.
American Journal of Medical Quality : the Official Journal of the American College of Medical Quality|July 24, 2012
Improved patient safety and outcomes with a comprehensive interdisciplinary improvement initiative in kidney transplant recipientsDavid J Taber, Nicole A Pilch, John W McGillicuddy, et al.
The Annals of Pharmacotherapy|September 9, 2021
A Critical Analysis of the Specific Pharmacist Interventions and Risk Assessments During the 12-Month TRANSAFE Rx Randomized Controlled TrialHaley M Gonzales, James N Fleming, Mulugeta Gebregziabher, et al.
Transplantation Proceedings|December 23, 2008
Long-term efficacy of induction therapy with anti-interleukin-2 receptor antibodies or thymoglobulin compared with no induction therapy in renal transplantationD J Taber, N A Weimert, F Henderson, et al.
Clinical Journal of the American Society of Nephrology : CJASN|December 17, 2016
A Comparative Effectiveness Analysis of Early Steroid Withdrawal in Black Kidney Transplant RecipientsDavid J Taber, Kelly J Hunt, Mulugeta Gebregziabher, et al.
Annals of Surgery|June 28, 2017
Cytolytic Induction Therapy Improves Clinical Outcomes in African-American Kidney Transplant RecipientsDavid J Taber, John W McGillicuddy, Charles F Bratton, et al.
Journal of the American College of Surgeons|March 15, 2022
Early Assessment of National Kidney Allocation Policy ChangeVinayak S Rohan, Nicole Pilch, John McGillicuddy, et al.
Journal of the American College of Surgeons|February 5, 2017
Impact of the New Kidney Allocation System on Perioperative Outcomes and Costs in Kidney TransplantationDavid J Taber, Derek DuBay, John W McGillicuddy, et al.
Kidney International|August 25, 2016
Twenty years of evolving trends in racial disparities for adult kidney transplant recipientsDavid J Taber, Mulugeta Gebregziabher, Kelly J Hunt, et al.
Pageof 21